bourva

Samsung Biologics Revenue

₩46.05T FY2024
207940 · Samsung Biologics Prices delayed ≥15 min Sample data

Revenue over time

Revenue by period

Period Revenue
FY2024 ₩46.05T
FY2023 ₩42.01T
FY2022 ₩34.75T
FY2021 ₩28.61T
FY2020 ₩24.84T
Find your next idea
Screen stocks and ETFs across every market.